Medgenics, Inc. (NYSE: MDGN) today announced the pricing of 5,125,000 shares of its common stock in a previously announced underwritten ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE